EN HU
logo Tudóstér

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport
University of Debrecen
Research Groups
HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

Publication list

statistics filterable publication list
Uploaded publications:
34
Publications in DEA:
34
OA:
30
Date range:
2022-2025
2025
1.
Nagy, L., Nagy, G., Juhász, T., Fillér, C., Szűcs, G., Szekanecz, Z., Vereb, G., Antal-Szalmás, P., Szöőr, Á.: Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: insights into Fibrosis and Autoimmunity for Translational Research.
Int. J. Mol. Sci. 26 (6), 1-15, (article identifier: 2618), 2025.
doi DEA
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
2.
Pourjamal, N., Le Joncour, V., Vereb, G., Honkamaki, C., Isola, J., Leyton, J. V., Laakkonen, P., Joensuu, H., Barok, M.: Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Translational Oncology. 53, 1-9, (article identifier: 102284), 2025.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
3.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: EGFR-HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry - Implications for Targeted Therapy.
Cytom. Part A. 107 (3), 187-202, 2025.
doi DEA WoS Scopus
Journal metrics:
Q3 Cell Biology (2024)
Q1 Histology (2024)
Q1 Pathology and Forensic Medicine (2024)
4.
Gergely, B., Vereb, M. A., Rebenku, I., Vereb, G., Szöőr, Á.: Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
5.
Sipos, A., Kerekes, É., Szeőcs, D., Szarvas, F., Schwarcz, S., Tóth, E., Ujlaki, G., Mikó, E., Bai, P.: Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation.
Cell Death Discov. 11 (1), 1-10, (article identifier: 134), 2025.
doi DEA WoS Scopus
Journal metrics:
Q1 Cancer Research (2024)
Q1 Cell Biology (2024)
Q1 Cellular and Molecular Neuroscience (2024)
Q1 Immunology (2024)
2024
6.
Kovács, P., Schwarcz, S., Nyerges, P., Bíró, T. I., Ujlaki, G., Bai, P., Mikó, E.: Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models.
Front. Cell. Dev. Biol. 12, 1-14, (article identifier: 1487685), 2024.
doi DEA
Journal metrics:
Q1 Cell Biology
Q1 Developmental Biology
7.
Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E. A., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z. T., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
GeroScience. 46 (4), 3581-3597, 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
8.
Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
9.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Correction to "Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening".
J. Chem Inf. Model. 64 (24), 9651, 2024.
doi DEA Scopus
10.
Schwarcz, S., Nyerges, P., Bíró, T. I., Janka, E. A., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
Molecules. 29 (13), 1-16, (article identifier: 3073), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q2 Molecular Medicine
Q1 Organic Chemistry
Q1 Pharmaceutical Science
Q1 Physical and Theoretical Chemistry
11.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
Int. J. Mol. Sci. 25 (11), 1-20, (article identifier: 5978), 2024.
doi DEA Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
12.
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.
doi DEA WoS Scopus
Journal metrics:
D1 Medicine (miscellaneous)
13.
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., Bai, P.: Guideline for designing microbiome studies in neoplastic diseases.
GeroScience. 46 (5), 4037-4057, 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
14.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Identification of a Novel Structural Class of Hv1 Inhibitors by Structure-Based Virtual Screening.
J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Chemical Engineering (miscellaneous)
Q1 Chemistry (miscellaneous)
Q1 Computer Science Applications
D1 Library and Information Sciences
15.
Kormos, J., Daróczi, L., Szöllősi, J., Mátyus, L., Jenei, A.: Novel transmission electron microscopic method to quantify protein clustering on the cell surface.
Curr. Protoc. 4 (5), 1-14, (article identifier: 1045), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Health Informatics
D1 Immunology and Microbiology (miscellaneous)
D1 Medical Laboratory Technology
Q1 Neuroscience (miscellaneous)
D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
16.
Sturniolo, I., Váróczy, C., Regdon, Z., Türk-Mázló, A., Muzsai, S., Bácsi, A., Intili, G., Hegedűs, C., Boothby, M. R., Holechek, J., Ferraris, D., Schüler, H., Virág, L.: PARP14 contributes to the development of the tumor-associated macrophage phenotype.
Int. J. Mol. Sci. 25 (7), 1-21, (article identifier: 3601), 2024.
doi DEA WoS Scopus
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
17.
Oit-Wiscombe, I., Virág, L., Kilk, K., Soomets, U., Altraja, A.: Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD.
Antioxidants. 13 (8), 1-14, (article identifier: 953), 2024.
doi DEA
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q1 Molecular Biology
Q1 Physiology
18.
Sturniolo, I., Váróczy, C., Bede, Á. M., Hegedűs, C., Demény, M. Á., Virág, L.: Quantifying antibody-dependent cellular cytotoxicity in a tumor spheroid model: application for drug discovery.
J. Vis. Exp. 206, 1-14, (article identifier: 65922), 2024.
doi DEA WoS Scopus
Journal metrics:
Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2 Chemical Engineering (miscellaneous)
Q3 Immunology and Microbiology (miscellaneous)
Q3 Neuroscience (miscellaneous)
19.
Szántó, M., Yélamos, J., Bai, P.: Specific and shared biological functions of PARP2-is PARP2 really a lil' brother of PARP1?.
Expert Rev. Mol. Med. 26, 1-21, (article identifier: 13), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Molecular Biology
Q1 Molecular Medicine
20.
Schwarcz, S., Kovács, P., Nyerges, P., Ujlaki, G., Sipos, A., Uray, K., Bai, P., Mikó, E.: The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma.
Cell Death Discov. 10 (1), 1-12, 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
21.
Papp, H., Tóth, E., Bóvári-Biri, J., Bánfai, K., Juhász, P., Mahdi, M., Russo, L. C., Bajusz, D., Sipos, A., Petri, L., Szalai, T. V., Kemény, Á., Madai, M., Kuczmog, A., Batta, G., Mózner, O., Vaskó, D., Hirsch, E., Bohus, P., Méhes, G., Tőzsér, J., Curtin, N., Helyes, Z., Tóth, A., Hoch, N. C., Jakab, F., Keserű, G. M., Pongrácz, J., Bai, P.: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Br. J. Pharmacol. 181 (23), 4782-4803, 2024.
doi DEA WoS Scopus
Journal metrics:
D1 Pharmacology
22.
Nagy, L., Mezősi-Csaplár, M., Rebenku, I., Vereb, G., Szöőr, Á.: Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
doi DEA WoS Scopus
Journal metrics:
Q1 Immunology
Q1 Immunology and Allergy
2023
23.
Szántó, G. T., Fehér, Á., Korpos, É., Gyöngyösi, A., Kállai, J., Mészáros, B., Óvári, K., Lányi, Á., Panyi, G., Varga, Z.: 5-Chloro-2-Guanidinobenzimidazole (ClGBI) Is a Non-Selective Inhibitor of the Human HV1 Channel.
Pharmaceuticals (Basel). 16 (5), 1-15, (article identifier: 656), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
24.
Skopál, A., Ujlaki, G., Gerencsér, A. T., Bankó, C., Bacsó, Z., Ciruela, F., Virág, L., Haskó, G., Kókai, E.: Adenosine A2A Receptor Activation Regulates Niemann-Pick C1 Expression and Localization in Macrophages.
Curr. Issues Mol. Biol. 45 (6), 4948-4969, 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Microbiology
Q2 Microbiology (medical)
Q3 Molecular Biology
25.
Mezősi-Csaplár, M., Szöőr, Á., Vereb, G.: CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.
doi DEA WoS Scopus
Journal metrics:
Q2 Cancer Research
Q1 Oncology
DEENK University of Debrecen
© 2012 University of Debrecen
We use cookies on this site to enhance your user experience. By continuing to use the site, you agree to the use of cookies.